Catalyst Wire Dossier Catalyst Wire Dossier

Subcutaneous immunotherapy (unspecified) for Phleum pratense

· Roxall Medicina España S.A
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subcutaneous immunotherapy (unspecified) for Phleum pratense, covering 2019-04-29 to 2019-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense [Phase 2]

See pricing